Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
526 |
|
Actual shortage: | 143 (27%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 1 (0%) | |
Resolved: | 382 (73%) | |
Discontinuation Reports |
14 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 14 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
125 (23%) |
|
Overdue reports |
77 (54%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
JAMP TELMISARTAN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-09-26 | 169425 |
JAMP TELMISARTAN | 80MG | TABLET | Resolved | 2022-09-16 | 2022-09-26 | 169428 |
JAMP TELMISARTAN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-10-24 | 169449 |
JAMP TELMISARTAN | 40MG | TABLET | Resolved | 2022-11-09 | 2023-01-10 | 174099 |
JAMP TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2024-02-07 | 2024-04-29 | 218723 |
JAMP SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-12-09 | 2023-05-03 | 177828 |
JAMP SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-12-09 | 2023-04-03 | 177831 |
JAMP ROSUVASTATIN CALCIUM | 20MG | TABLET | Resolved | 2022-08-03 | 2022-08-30 | 165935 |
JAMP ROSUVASTATIN CALCIUM | 20MG | TABLET | Resolved | 2023-01-09 | 2023-02-03 | 180286 |
JAMP ROSUVASTATIN CALCIUM | 40MG | TABLET | Resolved | 2023-01-09 | 2023-02-09 | 180289 |
JAMP RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2022-02-14 | 2022-06-10 | 154925 |
JAMP RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2022-02-14 | 2022-06-13 | 154928 |
JAMP RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2022-02-14 | 2022-06-13 | 154940 |
JAMP RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2022-04-06 | 2022-06-13 | 158103 |
JAMP RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2022-04-06 | 2022-06-13 | 158106 |
JAMP REPAGLINIDE | 0.5MG | TABLET | Resolved | 2017-04-10 | 2020-04-29 | 6358 |
JAMP REPAGLINIDE | 1.0MG | TABLET | Resolved | 2017-04-10 | 2020-04-29 | 6361 |
JAMP REPAGLINIDE | 2.0MG | TABLET | Resolved | 2017-04-10 | 2020-04-29 | 6364 |
JAMP RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-01-09 | 2023-01-31 | 180283 |
JAMP RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2023-09-11 | 2024-04-29 | 204044 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
Showing 1 to 14 of 14